华东医药股价微涨0.07% 口服减重药Ⅱ期临床结果出炉

Group 1 - The latest stock price of Huadong Medicine is 43.76 yuan, with a slight increase of 0.03 yuan from the previous trading day. The trading volume was 87,670 hands, with a transaction amount of 381 million yuan, and the stock price fluctuated between 42.90 yuan and 43.95 yuan [1] - Huadong Medicine's main business includes three segments: pharmaceutical industry, pharmaceutical commerce, and medical aesthetics. The company is a leading pharmaceutical commercial enterprise in Zhejiang Province, possessing a complete pharmaceutical industry value chain. In the pharmaceutical industry, the company focuses on three core therapeutic areas: anti-tumor, endocrine, and autoimmune diseases [1] - The company's self-developed innovative drug HDM1002 has shown positive progress in Phase II clinical trials for weight loss. Research data indicates that in the 400mg QD dosage group, after 12 weeks of administration, participants' weight decreased by 6.83% compared to baseline, significantly outperforming the placebo group. Most adverse reactions were mild, with no severe adverse events observed. The Phase III clinical study for this weight loss drug has been approved to commence [1] Group 2 - On August 4, the net outflow of main funds was 2.7276 million yuan, with a cumulative net outflow of 78.604 million yuan over the past five trading days [1]